Despite being introduced in clinical practice more than 20 years ago, selection criteria for
deep brain stimulation (DBS) in Parkinson's disease (PD) rely on a document published in …

Abstract Development of motor fluctuations and dyskinesia characterizes the transition from
early to advanced Parkinson disease stage. Current therapeutic strategies to manage motor …

Objective: The aim of this study was to investigate the efficacy and safety of deep-brain
stimulation (DBS) in the treatment of patients with Parkinson's disease aged 75 years and …

The EARLYSTIM Study compared deep brain stimulation (DBS) with best medical treatment
(BMT) over 2-years, showing a between-group difference of 8.0 from baseline in favor of …

Background Camptocormia is an axis symptom of Parkinson disease. It remains uncertain
whether treatment with medications and surgery are effective. In this study, we assessed the …

Background The availability of deep brain stimulation (DBS), a highly efficacious treatment
for several movement disorders, remains low in developing countries, with scarce data …

Deep Brain Stimulation (DBS) is an effective treatment option for patients with dopaminergic
complications of Parkinson's disease (PD) and drug-refractory PD tremor. However, DBS …

Epilepsy is one of the most common neurological diseases and affects 1–2% of the world's
population. Epilepsy is associated with recurrent and unpredictable seizures. Since 20% of …

Deep brain stimulation (DBS) interventions are novel devices being investigated for the
management of severe treatment-resistant psychiatric illnesses. These interventions require …

Introduction: Deep brain stimulation (DBS) is an established therapy for Parkinson's disease
(PD) that can significantly improve motor symptoms and quality of life. Despite its …